Slideshow: Pharmacist’s Role in Infectious Disease Management | ASHP Midyear

Four posters at the American Society of Health-System Pharmacy 2024 Midyear Clinical Meeting and Exhibition—held December 8 to 12, 2024, in New Orleans, Louisiana—focused on infectious disease considerations in sexually transmitted infections, HIV, and urinary tract infections.

Follow along with our coverage of the 2024 ASHP Midyear Clinical Meeting and Exhibition here.

References

1. Ford M, Boyajian M. Adherence to the 2020 CDC treatment guidelines for gonorrhea and chlamydia in adults presenting to community medical centers emergency departments. Presented at: American Society of Health-System Pharmacists 2024 Midyear Clinical Meeting and Exhibition; December 8-12, 2024; New Orleans, LA. Poster 8-055.

2. Gerber A, Mgbao O, Kaplan-Lewis E, Casey E, Pitts R. Evaluating the impact of collaborative drug therapy management pharmacists on patients initiated on long-acting injectable PrEP in New York City: Finding from the EquiPrEP study. Presented at: American Society of Health-System Pharmacists 2024 Midyear Clinical Meeting and Exhibition; December 8-12, 2024; New Orleans, LA. Poster 8-056.

3. Eller AA, Vo S, Haar S, Garcia B, Pullinger B. Three-day ceftriaxone versus longer antibiotic durations for complicated and uncomplicated cystitis. Presented at: American Society of Health-System Pharmacists 2024 Midyear Clinical Meeting and Exhibition; December 8-12, 2024; New Orleans, LA. Poster 4-041.

4. Bell A, Dandachi D, Shalit P, Torres JA, Nelson KL. Influencers and decision-making factors for choosing injectable PrEP among men who have sex with men and transgender men in the United States. Presented at: American Society of Health-System Pharmacists 2024 Midyear Clinical Meeting and Exhibition; December 8-12, 2024; New Orleans, LA. Poster 4-043.